Screener
Charles River Laboratories CRL Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesFairValueDisclosure.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Level 1 | Level 2 | Level 3 | Total |
|---|---|---|---|---|
| Other assets measured at fair value: | ||||
| Life insurance policies | — | $75,331 | — | $75,331 |
| Total assets measured at fair value | — | $75,331 | — | $75,331 |
| Accrued liabilities measured at fair value: | ||||
| Contingent consideration | — | — | $22,500 | $22,500 |
| Other long-term liabilities measured at fair value: | ||||
| Contingent consideration | — | — | $22,500 | $22,500 |
| Total liabilities measured at fair value | — | — | $45,000 | $45,000 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's total liabilities?
- Charles River Laboratories (CRL) reported total liabilities of $45M in Q2 2026.
- How has Charles River Laboratories's total liabilities changed year-over-year?
- Charles River Laboratories's total liabilities decreased by 98.9% year-over-year, from $4.16B to $45M.
- What is the long-term trend for Charles River Laboratories's total liabilities?
- Over 5 years (2020 to 2025), Charles River Laboratories's total liabilities has grown at a -61.1% compound annual growth rate (CAGR), from $3.35B to $30M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Charles River Laboratories's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude